Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$215,604,397
+$189,031,252 QoQ
Shares Held
856,797
+601.3% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#148
of 4,153 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. ABBV ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,604,397 | 856,797 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $26,573,145 | 122,181 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $42,762,891 | 184,689 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $58,788,267 | 316,713 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $75,824,240 | 361,895 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $114,610,991 | 644,969 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $90,672,744 | 459,149 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,400,852 | 183,074 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,602,328 | 85,680 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $54,101,266 | 349,108 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,695,055 | 71,750 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,045,502 | 67,138 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,539,720 | 15,936 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $431,606,878 | 3,215,907 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $654,147,738 | 4,271,009 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $754,155,497 | 4,652,122 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $119,631,722 | 883,543 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $206,354,447 | 1,912,992 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,232,591 | 108,599 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $14,079,422 | 130,100 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $22,160,270 | 253,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,239,940 | 33,000 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $438,480,840 | 5,755,097 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||